저자의 연구 키워드

저자의 연구 키워드

#5-HT3 receptor antagonist

#공공연구기관

#기술라이센싱

#기술료체계

#기술이전

#다세대제품

#무어의 법칙

#베이지안 접근 방법

#보상체계

#소비자 선호

#이산선택모델

#차세대 무선 이동통신 단말기

#컨조인트 분석

#학습곡선

#혼합로짓 모형

#확산모델

#Adjuvant chemoradiotherapy

#Anthracycline

#Antiemetics

#Antineoplastic agents

#bcl-2

#Belotecan

#Benign

#Biliary tract neoplasms

#Blood platelets

#Breast neoplasms

#CA 19-9 antigen

#Carcinoembryonic antigen

#CDMA

#Chemoradiotherapy

#Chemotherapy

#Cisplatin

#Colorectal neoplams

#Colorectal neoplasms

#Conjoint Analysis

#Consumer Preference

#Cyclooxygenase 2

#Diabetes mellitus

#Diffusion

#Digital convergence

#Discrete Choice

#DLC1 protein

#DNA methylation

#Dolasetron mesylate

#drug resistance

#Epigenomics

#Export-driven Growth Strategy

#Fluorescence

#Gastric Cancer

#G-CSF)

#Gemcitabine

#genetic

#Genetic polymorphism

#Granulocyte colony-stimulating factor

#HER2

#HER2-positive gastric cancer

#histone deacetylases

#Histone modification

#Horizontal regulation framework

#human

#In Situ Hybridization

#Input-output Analysis

#Input-output Table

#Interleukin-1beta

#Korea

#KX-01

#lapatinib

#Layers model

#Learning by doing

#Leukocytes

#LPHN2

#Mediastinal lymph node

#Metformin

#Microtubules

#Mitotic catastrophe

#Mobile Communication

#Moore′s law

#Multi-generation product

#Nausea

#Neoadjuvant therapy

#Neoplasm metastasis

#Neutropenia

#New Convergence Broadcasting Service

#Nomograms

#Non-small cell lung carcinoma

#Ondansetron

#OPB-31121

#Oxaliplatin

#p300-CBP transcription factors

#p53

#Paclitaxel

#Pancreatectomy

#Pancreatic neoplasms

#Phase I

#phosphoproteins

#Prevention

#Prognosis

#promoter regions

#Pulmonary nodule

#Q-Exactive

#Regorafenib

#RNA stability

#Segmental mastectomy

#Sinusoidal obstruction syndrome

#Smad3

#Solid tumor

#Sp1 transcription factor

#Splenic artery

#Splenomegaly

#SQ Index

#Src kinase inhibitor

#STAT3

#STAT3 inhibitor

#Stomach neoplasms

#Synergism

#Taxane

#Telecommunication and Broadcasting Convergence

#therapeutic targets

#Trade Specialization Index

#Transforming growth factor beta

#Transforming growth factor beta1

#Trastuzumab

#trichostation A

#Triple negative breast neoplasms

#Tristetraprolin

#Tumor biomarker

#Vascular endothelial growth factor

#Vertical regulation framework

#Vinorelbine

#Vomiting